(MedPage Today) — WASHINGTON — Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary syndrome (PCOS), the primary…
Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118429
Author :
Publish date : 2025-11-10 21:57:00
Copyright for syndicated content belongs to the linked Source.
